These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24347661)

  • 1. Changes in geographic variation in the use of percutaneous coronary intervention for stable ischemic heart disease after publication of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.
    Mohan AV; Fazel R; Huang PH; Shen YC; Howard D
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):125-30. PubMed ID: 24347661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trend in percutaneous coronary intervention volume following the COURAGE and BARI-2D trials: insight from over 8.1 million percutaneous coronary interventions.
    Bangalore S; Gupta N; Généreux P; Guo Y; Pancholy S; Feit F
    Int J Cardiol; 2015 Mar; 183():6-10. PubMed ID: 25662046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent changes in practice of elective percutaneous coronary intervention for stable angina.
    Ahmed B; Dauerman HL; Piper WD; Robb JF; Verlee MP; Ryan TJ; Goldberg D; Boss RA; Phillips WJ; Fedele F; Butzel D; Malenka DJ;
    Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):300-5. PubMed ID: 21505155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
    Shaw LJ; Berman DS; Maron DJ; Mancini GB; Hayes SW; Hartigan PM; Weintraub WS; O'Rourke RA; Dada M; Spertus JA; Chaitman BR; Friedman J; Slomka P; Heller GV; Germano G; Gosselin G; Berger P; Kostuk WJ; Schwartz RG; Knudtson M; Veledar E; Bates ER; McCallister B; Teo KK; Boden WE;
    Circulation; 2008 Mar; 117(10):1283-91. PubMed ID: 18268144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention.
    Vranckx P; Kalesan B; Stefanini GG; Farooq V; Onuma Y; Silber S; de Vries T; Jüni P; Serruys PW; Windecker S
    EuroIntervention; 2015 Jun; 11(2):171-9. PubMed ID: 24531331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate of percutaneous coronary intervention for the management of acute coronary syndromes and stable coronary artery disease in the United States (2007 to 2011).
    Kim LK; Feldman DN; Swaminathan RV; Minutello RM; Chanin J; Yang DC; Lee MK; Charitakis K; Shah A; Kaple RK; Bergman G; Singh H; Wong SC
    Am J Cardiol; 2014 Oct; 114(7):1003-10. PubMed ID: 25118124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial.
    Acharjee S; Teo KK; Jacobs AK; Hartigan PM; Barn K; Gosselin G; Tanguay JF; Maron DJ; Kostuk WJ; Chaitman BR; Mancini GB; Spertus JA; Dada MR; Bates ER; Booth DC; Weintraub WS; O'Rourke RA; Boden WE;
    Am Heart J; 2016 Mar; 173():108-17. PubMed ID: 26920603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving concepts in selecting optimal strategies for the management of patients with stable coronary disease: pharmacologic or revascularization therapy.
    Tandar A; Boden WE
    Curr Opin Cardiol; 2009 Nov; 24(6):591-5. PubMed ID: 19752728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal Trends and Outcomes of Percutaneous Coronary Interventions in Nonagenarians: A National Perspective.
    Goel K; Gupta T; Gulati R; Bell MR; Kolte D; Khera S; Bhatt DL; Rihal CS; Holmes DR
    JACC Cardiovasc Interv; 2018 Sep; 11(18):1872-1882. PubMed ID: 30236360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
    Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies in stable ischemic heart disease: lessons from the COURAGE and BARI-2D trials.
    Fernandez SF; Boden WE
    Curr Atheroscler Rep; 2010 Nov; 12(6):423-31. PubMed ID: 20845088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Characteristics and Outcomes of Veterans With Stable Ischemic Heart Disease Enrolled in the COURAGE Trial Versus the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.
    Smilowitz NR; Carey EP; Shah B; Hartigan PM; Plomondon ME; Maron DJ; Maddox TM; Spertus JA; Mancini GBJ; Chaitman BR; Weintraub WS; Sedlis SP; Boden WE;
    Am J Cardiol; 2022 Oct; 180():1-9. PubMed ID: 35918234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
    Zhang Z; Jones P; Weintraub WS; Mancini GBJ; Sedlis S; Maron DJ; Teo K; Hartigan P; Kostuk W; Berman D; Boden WE; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003971. PubMed ID: 29752388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.
    Borden WB; Redberg RF; Mushlin AI; Dai D; Kaltenbach LA; Spertus JA
    JAMA; 2011 May; 305(18):1882-9. PubMed ID: 21558519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia.
    Gada H; Kirtane AJ; Kereiakes DJ; Bangalore S; Moses JW; Généreux P; Mehran R; Dangas GD; Leon MB; Stone GW
    Am J Cardiol; 2015 May; 115(9):1194-9. PubMed ID: 25759103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in PCI volume after negative results from the COURAGE trial.
    Howard DH; Shen YC
    Health Serv Res; 2014 Feb; 49(1):153-70. PubMed ID: 23829189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS.
    Généreux P; Madhavan MV; Mintz GS; Maehara A; Palmerini T; Lasalle L; Xu K; McAndrew T; Kirtane A; Lansky AJ; Brener SJ; Mehran R; Stone GW
    J Am Coll Cardiol; 2014 May; 63(18):1845-54. PubMed ID: 24561145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention.
    Shaw LJ; Weintraub WS; Maron DJ; Hartigan PM; Hachamovitch R; Min JK; Dada M; Mancini GB; Hayes SW; O'Rourke RA; Spertus JA; Kostuk W; Gosselin G; Chaitman BR; Knudtson M; Friedman J; Slomka P; Germano G; Bates ER; Teo KK; Boden WE; Berman DS
    Am Heart J; 2012 Aug; 164(2):243-50. PubMed ID: 22877811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Patients Undergoing Percutaneous Coronary Intervention in Contemporary U.S. Practice With ISCHEMIA Trial Population.
    Chatterjee S; Fanaroff AC; Parzynski C; Curtis J; Kolansky DM; Maddox TM; Mukherjee D; Yeh RW; Giri J
    JACC Cardiovasc Interv; 2021 Nov; 14(21):2344-2349. PubMed ID: 34736733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2017 Versus 2012 Appropriate Use Criteria for Percutaneous Coronary Interventions: Impact on Appropriateness Ratings.
    Hannan EL; Samadashvili Z; Cozzens K; Berger PB; Chikwe J; Jacobs AK; Walford G; Ling FSK; Venditti FJ; Gold J; King SB
    JACC Cardiovasc Interv; 2018 Mar; 11(5):473-478. PubMed ID: 29519380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.